U.S. Dietary Supplements Market Size, Share & Trends Analysis Report By Ingredient (Single Ingredient, Multi-Ingredients), By Application, By End Use, By Form, By Type, By Distribution Channel, And Segment Forecasts, 2026 - 2033
Description
U.S. Dietary Supplements Market Summary
The U.S. dietary supplements market size was estimated at USD 68.74 billion in 2025 and is projected to reach USD 131.08 billion by 2033, growing at a CAGR of 8.5% from 2026 to 2033. The market is primarily driven by rising health consciousness, an aging population, an increasing prevalence of lifestyle-related conditions, and a growing focus on preventive healthcare.
Consumers are proactively seeking ways to boost immunity, improve mental well-being, manage stress, and support overall health, especially after the COVID-19 pandemic. In addition, the popularity of fitness and wellness culture, coupled with greater access to health information through digital platforms, has empowered individuals to take control of their nutritional needs. The expansion of e-commerce, advancements in personalized nutrition, and the availability of innovative product formats like gummies and functional beverages have further fueled market growth.
Nutraceuticals are active components that offer various health benefits. Owing to their safety profile, nutritional benefits, and therapeutic effects, nutraceutical products have gained recognition across the globe. They are known to provide nutrition, support therapy for treatment, prevent a wide range of diseases, and reduce side effects caused by cancer radiotherapy and chemotherapy.
Health and wellness awareness has risen significantly among consumers adopting supplements that align with their goals of staying healthy and fit. As a result, the U.S. dietary supplements industry is poised for continued expansion. Supplement brands and entrepreneurs closely monitor these shifts, identifying new product opportunities within this dynamic sector. In addition, consumers are actively seeking supplement solutions to address evolving lifestyles and cope with heightened stress levels. Consumers further believe that dietary supplements are essential and help in maintaining health. The demand for immune-boosting supplements has surged, driven by concerns about COVID-19, diabetes, and other infectious diseases. Particularly popular are supplements targeting respiratory health. In addition, the trend of stress, sleep, and mental health support has gained momentum, with consumers seeking convenient solutions to enhance mood and overall well-being. This has resulted in a demand for supplements that address these concerns.
Herbal supplements, including Ginseng, Ashwagandha, Bacopa, and Lion’s Mane, alongside ingredients such as melatonin, valerian root, glycine, and B complex vitamins, are experiencing increased popularity in the U.S. as they support cognitive health, stress relief, and better sleep.
In February 2024, the FDA launched the "Information on Select Dietary Supplement Ingredients and Other Substances," a new directory of ingredients used in dietary supplements. This directory replaces the previous Dietary Supplement Ingredient Directory released in 2023 and aims to provide the public with information on FDA commentary and actions regarding specific ingredients in dietary supplements. By providing a comprehensive directory of ingredients used in dietary supplements along with FDA commentary and actions, this initiative aims to provide consumers with valuable information to make informed choices about supplement consumption. Moreover, it underscores the FDA's commitment to ensuring the safety and proper regulation of dietary supplement ingredients, particularly focusing on new dietary ingredients. This initiative is expected to raise industry standards, promote consumer confidence, and ultimately contribute to a safer and more regulated dietary supplements industry in the U.S.
Furthermore, the pandemic resulted in inactive lifestyles, leading to increased weight gain and joint stiffness among consumers. As a result, a surge in demand for joint health products, including supplements, was observed. As consumers strive to regain fitness and vitality, adopting dietary supplements continues to rise, driving market growth. Consumers are increasingly engaging in healthy behavior, such as exercising regularly and incorporating a healthy diet, resulting in high penetration of dietary supplements.
U.S. Dietary Supplements Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. dietary supplements market report on the basis of ingredient, form, application, end use, type, and distribution channel.
The U.S. dietary supplements market size was estimated at USD 68.74 billion in 2025 and is projected to reach USD 131.08 billion by 2033, growing at a CAGR of 8.5% from 2026 to 2033. The market is primarily driven by rising health consciousness, an aging population, an increasing prevalence of lifestyle-related conditions, and a growing focus on preventive healthcare.
Consumers are proactively seeking ways to boost immunity, improve mental well-being, manage stress, and support overall health, especially after the COVID-19 pandemic. In addition, the popularity of fitness and wellness culture, coupled with greater access to health information through digital platforms, has empowered individuals to take control of their nutritional needs. The expansion of e-commerce, advancements in personalized nutrition, and the availability of innovative product formats like gummies and functional beverages have further fueled market growth.
Nutraceuticals are active components that offer various health benefits. Owing to their safety profile, nutritional benefits, and therapeutic effects, nutraceutical products have gained recognition across the globe. They are known to provide nutrition, support therapy for treatment, prevent a wide range of diseases, and reduce side effects caused by cancer radiotherapy and chemotherapy.
Health and wellness awareness has risen significantly among consumers adopting supplements that align with their goals of staying healthy and fit. As a result, the U.S. dietary supplements industry is poised for continued expansion. Supplement brands and entrepreneurs closely monitor these shifts, identifying new product opportunities within this dynamic sector. In addition, consumers are actively seeking supplement solutions to address evolving lifestyles and cope with heightened stress levels. Consumers further believe that dietary supplements are essential and help in maintaining health. The demand for immune-boosting supplements has surged, driven by concerns about COVID-19, diabetes, and other infectious diseases. Particularly popular are supplements targeting respiratory health. In addition, the trend of stress, sleep, and mental health support has gained momentum, with consumers seeking convenient solutions to enhance mood and overall well-being. This has resulted in a demand for supplements that address these concerns.
Herbal supplements, including Ginseng, Ashwagandha, Bacopa, and Lion’s Mane, alongside ingredients such as melatonin, valerian root, glycine, and B complex vitamins, are experiencing increased popularity in the U.S. as they support cognitive health, stress relief, and better sleep.
In February 2024, the FDA launched the "Information on Select Dietary Supplement Ingredients and Other Substances," a new directory of ingredients used in dietary supplements. This directory replaces the previous Dietary Supplement Ingredient Directory released in 2023 and aims to provide the public with information on FDA commentary and actions regarding specific ingredients in dietary supplements. By providing a comprehensive directory of ingredients used in dietary supplements along with FDA commentary and actions, this initiative aims to provide consumers with valuable information to make informed choices about supplement consumption. Moreover, it underscores the FDA's commitment to ensuring the safety and proper regulation of dietary supplement ingredients, particularly focusing on new dietary ingredients. This initiative is expected to raise industry standards, promote consumer confidence, and ultimately contribute to a safer and more regulated dietary supplements industry in the U.S.
Furthermore, the pandemic resulted in inactive lifestyles, leading to increased weight gain and joint stiffness among consumers. As a result, a surge in demand for joint health products, including supplements, was observed. As consumers strive to regain fitness and vitality, adopting dietary supplements continues to rise, driving market growth. Consumers are increasingly engaging in healthy behavior, such as exercising regularly and incorporating a healthy diet, resulting in high penetration of dietary supplements.
U.S. Dietary Supplements Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. dietary supplements market report on the basis of ingredient, form, application, end use, type, and distribution channel.
- Ingredient Type Outlook (Revenue, USD Million, 2021 - 2033)
- Vitamin
- Multivitamin
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Vitamin K
- Vitamin E
- Botanicals
- Minerals
- Calcium
- Potassium
- Magnesium
- Iron
- Zinc
- Others (selenium, chromium, copper)
- Proteins & Amino Acids
- Collagen
- Others
- Fibers & Specialty Carbohydrates
- Omega Fatty Acids
- Probiotics
- Prebiotics & Postbiotics
- Others
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- OTC
- Prescribed
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- End User Outlook (Revenue, USD Million, 2021 - 2033)
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Offline
- Hypermarkets/Supermarkets
- Pharmacies
- Specialty Stores
- Practioner
- Others (Direct to Consumer, MLM)
- Online
- Amazon
- Other Online Retail Stores
- Ingredient-Form Outlook (Revenue, USD Million, 2021 - 2033)
- Vitamin
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Multivitamin
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin A
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin B
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin C
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin D
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin K
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Vitamin E
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Mineral
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Calcium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Potassium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Magnesium
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Iron
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Zinc
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others (selenium, chromium, copper)
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Botanicals
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Protein & amino acids
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Collagen
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Fibers & Specialty Carbohydrates
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Omega Fatty Acids
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Probiotics
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Prebiotics & Postbiotics
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Others
- Tablets
- Capsules
- Soft Gels
- Powders
- Gummies
- Liquid
- Others
- Form-End User Outlook (Revenue, USD Million, 2021 - 2033)
- Tablets
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Capsules
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Soft Gels
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Powders
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Gummies
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Liquid
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Others
- Adults
- Millennials
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen X
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Gen Z
- Male
- Female
- Pregnant Women
- Non-pregnant Women
- Boomers
- Male
- Female
- Geriatric
- Children
- Infants
- Form-Application Outlook (Revenue, USD Million, 2021 - 2033)
- Tablets
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Capsules
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Soft Gel
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Powder
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Gummies
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Liquid
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
- Others
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Cardiac Health
- Diabetes
- Anti-cancer
- Lungs Detox/Cleanse
- Skin/ Hair/ Nails
- Sexual Health
- Brain/Mental Health
- Insomnia
- Menopause
- Anti-aging
- Prenatal Health
- Others
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Ingredient Outlook
- 2.3. Type Outlook
- 2.4. Form Outlook
- 2.5. Application Outlook
- 2.6. End User Outlook
- 2.7. Distribution Channel Outlook
- 2.8. Product-Form Outlook
- 2.9. Form-End User Outlook
- 2.10. Form-Application Outlook
- 2.11. Competitive Landscape Snapshot
- Chapter 3. U.S. Dietary Supplements Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Related Market Outlook
- 3.2. Penetration and Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Sales Channel Analysis
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Market Opportunities
- 3.4.4. Market Challenges
- 3.5. Industry Analysis Tools
- 3.5.1. Porter’s Five Forces Analysis
- 3.6. Market Entry Strategies
- Chapter 4. U.S. Dietary Supplements Market: Consumer Behavior Analysis
- 4.1. Consumer Trends & Preferences
- 4.2. Factors Affecting Buying Decisions
- 4.3. Consumer Product Adoption
- 4.4. Observations & Recommendations
- Chapter 5. U.S. Dietary Supplements Market: Ingredient Estimates & Trend Analysis
- 5.1. U.S. Dietary Supplements Market, by Ingredient: Key Takeaways
- 5.2. Ingredient Movement Analysis & Market Share, 2025 & 2033
- 5.3. Market Estimates & Forecasts, by Ingredient, 2021 - 2033 (USD Million)
- 5.3.1. Vitamin
- 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.1.1.1. Multivitamin
- 5.3.1.1.2. Vitamin A
- 5.3.1.1.3. Vitamin B
- 5.3.1.1.4. Vitamin C
- 5.3.1.1.5. Vitamin D
- 5.3.1.1.6. Vitamin K
- 5.3.1.1.7. Vitamin E
- 5.3.2. Botanicals
- 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.3. Minerals
- 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.3.1.1. Calcium
- 5.3.3.1.2. Potassium
- 5.3.3.1.3. Magnesium
- 5.3.3.1.4. Iron
- 5.3.3.1.5. Zinc
- 5.3.3.1.6. Others (selenium, chromium, copper)
- 5.3.4. Proteins & Amino Acids
- 5.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.4.1.1. Collagen
- 5.3.4.1.2. Others
- 5.3.5. Fibers & Specialty Carbohydrates
- 5.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.6. Omega Fatty Acids
- 5.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.7. Probiotics
- 5.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.8. Prebiotics & Postbiotics
- 5.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3.9. Others
- 5.3.9.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 6. U.S. Dietary Supplements Market: Form Estimates & Trend Analysis
- 6.1. U.S. Dietary Supplements Market, by Form: Key Takeaways
- 6.2. Form Movement Analysis & Market Share, 2025 & 2033
- 6.3. Market Estimates & Forecasts, by Form, 2021 - 2033 (USD Million)
- 6.3.1. Tablets
- 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.2. Capsules
- 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.3. Soft gels
- 6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.4. Powders
- 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.5. Gummies
- 6.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.6. Liquids
- 6.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3.7. Others
- 6.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 7. U.S. Dietary Supplements Market: Type Estimates & Trend Analysis
- 7.1. U.S. Dietary Supplements Market, by Type: Key Takeaways
- 7.2. Type Movement Analysis & Market Share, 2025 & 2033
- 7.3. Market Estimates & Forecasts, by Type, 2021 - 2033 (USD Million)
- 7.3.1. OTC
- 7.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2. Prescribed
- 7.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 8. U.S. Dietary Supplements Market: Application Estimates & Trend Analysis
- 8.1. U.S. Dietary Supplements Market, by Application: Key Takeaways
- 8.2. Application Movement Analysis & Market Share, 2025 & 2033
- 8.3. Market Estimates & Forecasts, by Application, 2021 - 2033 (USD Million)
- 8.3.1. Bone & Joint Health
- 8.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.2. Gastrointestinal Health
- 8.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.3. Immunity
- 8.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.4. Cardiac Health
- 8.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.5. Diabetes
- 8.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.6. Anti-cancer
- 8.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.7. Lungs Detox/Cleanse
- 8.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.8. Skin/ Hair/ Nails
- 8.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.9. Sexual Health
- 8.3.9.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.10. Brain/Mental Health
- 8.3.10.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.11. Insomnia
- 8.3.11.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.12. Menopause
- 8.3.12.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.13. Anti-aging
- 8.3.13.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.14. Prenatal Health
- 8.3.14.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 8.3.15. Others
- 8.3.15.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 9. U.S. Dietary Supplements Market: End-User Estimates & Trend Analysis
- 9.1. U.S. Dietary Supplements Market, by End User: Key Takeaways
- 9.2. End User Movement Analysis & Market Share, 2024 & 2033
- 9.3. Market Estimates & Forecasts, by End User, 2021 - 2033 (USD Million)
- 9.3.1. Adults
- 9.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.1.1.1. Millennials
- 9.3.1.1.1.1. Male
- 9.3.1.1.1.2. Female
- 9.3.1.1.1.3. Pregnant Women
- 9.3.1.1.1.4. Non-pregnant Women
- 9.3.1.1.2. Gen X
- 9.3.1.1.2.1. Male
- 9.3.1.1.2.2. Female
- 9.3.1.1.2.3. Pregnant Women
- 9.3.1.1.2.4. Non-pregnant Women
- 9.3.1.1.3. Gen Z
- 9.3.1.1.3.1. Male
- 9.3.1.1.3.2. Female
- 9.3.1.1.3.3. Pregnant Women
- 9.3.1.1.3.4. Non-pregnant Women
- 9.3.1.1.4. Boomers
- 9.3.1.1.4.1. Male
- 9.3.1.1.4.2. Female
- 9.3.2. Geriatric
- 9.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.3. Children
- 9.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 9.3.4. Infants
- 9.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- Chapter 10. U.S. Dietary Supplements Market: Distribution Channel Estimates & Trend Analysis
- 10.1. U.S. Dietary Supplements Market, By Distribution Channel: Key Takeaways
- 10.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
- 10.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
- 10.3.1. Offline
- 10.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 10.3.1.1.1. Hypermarkets/Supermarkets
- 10.3.1.1.2. Pharmacies
- 10.3.1.1.3. Specialty Stores
- 10.3.1.1.4. Practioner
- 10.3.1.1.5. Others (Direct to Consumer, MLM)
- 10.3.2. Online
- 10.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 10.3.2.1.1. Amazon
- 10.3.2.1.2. Other Online Retail Stores
- Chapter 11. U.S. Dietary Supplements Market: Product-Form Estimates & Trend Analysis
- 11.1. U.S. Dietary Supplements Market, By Product-Form: Key Takeaways
- 11.2. Product-Form Movement Analysis & Market Share, 2024 & 2033
- 11.3. Market Estimates & Forecasts, by Product-Form, 2021 - 2033 (USD Million)
- 11.3.1. Vitamin
- 11.3.1.1. Tablets
- 11.3.1.2. Capsules
- 11.3.1.3. Soft Gels
- 11.3.1.4. Powders
- 11.3.1.5. Gummies
- 11.3.1.6. Liquid
- 11.3.1.7. Others
- 11.3.1.8. Multi-Vitamin
- 11.3.1.8.1. Tablets
- 11.3.1.8.2. Capsules
- 11.3.1.8.3. Soft Gels
- 11.3.1.8.4. Powders
- 11.3.1.8.5. Gummies
- 11.3.1.8.6. Liquid
- 11.3.1.8.7. Others
- 11.3.2. Vitamin A
- 11.3.2.1.1. Tablets
- 11.3.2.1.2. Capsules
- 11.3.2.1.3. Soft Gels
- 11.3.2.1.4. Powders
- 11.3.2.1.5. Gummies
- 11.3.2.1.6. Liquid
- 11.3.2.1.7. Others
- 11.3.3. Vitamin B
- 11.3.3.1.1. Tablets
- 11.3.3.1.2. Capsules
- 11.3.3.1.3. Soft Gels
- 11.3.3.1.4. Powders
- 11.3.3.1.5. Gummies
- 11.3.3.1.6. Liquid
- 11.3.3.1.7. Others
- 11.3.4. Vitamin C
- 11.3.4.1.1. Tablets
- 11.3.4.1.2. Capsules
- 11.3.4.1.3. Soft Gels
- 11.3.4.1.4. Powders
- 11.3.4.1.5. Gummies
- 11.3.4.1.6. Liquid
- 11.3.4.1.7. Others
- 11.3.5. Vitamin D
- 11.3.5.1.1. Tablets
- 11.3.5.1.2. Capsules
- 11.3.5.1.3. Soft Gels
- 11.3.5.1.4. Powders
- 11.3.5.1.5. Gummies
- 11.3.5.1.6. Liquid
- 11.3.5.1.7. Others
- 11.3.6. Vitamin K
- 11.3.6.1.1. Tablets
- 11.3.6.1.2. Capsules
- 11.3.6.1.3. Soft Gels
- 11.3.6.1.4. Powders
- 11.3.6.1.5. Gummies
- 11.3.6.1.6. Liquid
- 11.3.6.1.7. Others
- 11.3.7. Vitamin E
- 11.3.7.1.1. Tablets
- 11.3.7.1.2. Capsules
- 11.3.7.1.3. Soft Gels
- 11.3.7.1.4. Powders
- 11.3.7.1.5. Gummies
- 11.3.7.1.6. Liquid
- 11.3.7.1.7. Others
- 11.3.8. Mineral
- 11.3.8.1. Tablets
- 11.3.8.2. Capsules
- 11.3.8.3. Soft Gels
- 11.3.8.4. Powders
- 11.3.8.5. Gummies
- 11.3.8.6. Liquid
- 11.3.8.7. Others
- 11.3.8.7.1. Calcium
- 11.3.8.7.1.1. Tablets
- 11.3.8.7.1.2. Capsules
- 11.3.8.7.1.3. Soft Gels
- 11.3.8.7.1.4. Powders
- 11.3.8.7.1.5. Gummies
- 11.3.8.7.1.6. Liquid
- 11.3.8.7.1.7. Others
- 11.3.8.7.2. Potassium
- 11.3.8.7.2.1. Tablets
- 11.3.8.7.2.2. Capsules
- 11.3.8.7.2.3. Soft Gels
- 11.3.8.7.2.4. Powders
- 11.3.8.7.2.5. Gummies
- 11.3.8.7.2.6. Liquid
- 11.3.8.7.2.7. Others
- 11.3.8.7.3. Magnesium
- 11.3.8.7.3.1. Tablets
- 11.3.8.7.3.2. Capsules
- 11.3.8.7.3.3. Soft Gels
- 11.3.8.7.3.4. Powders
- 11.3.8.7.3.5. Gummies
- 11.3.8.7.3.6. Liquid
- 11.3.8.7.3.7. Others
- 11.3.8.7.4. Iron
- 11.3.8.7.4.1. Tablets
- 11.3.8.7.4.2. Capsules
- 11.3.8.7.4.3. Soft Gels
- 11.3.8.7.4.4. Powders
- 11.3.8.7.4.5. Gummies
- 11.3.8.7.4.6. Liquid
- 11.3.8.7.4.7. Others
- 11.3.8.7.5. Zinc
- 11.3.8.7.5.1. Tablets
- 11.3.8.7.5.2. Capsules
- 11.3.8.7.5.3. Soft Gels
- 11.3.8.7.5.4. Powders
- 11.3.8.7.5.5. Gummies
- 11.3.8.7.5.6. Liquid
- 11.3.8.7.5.7. Others
- 11.3.8.7.6. Others
- 11.3.8.7.6.1. Tablets
- 11.3.8.7.6.2. Capsules
- 11.3.8.7.6.3. Soft Gels
- 11.3.8.7.6.4. Powders
- 11.3.8.7.6.5. Gummies
- 11.3.8.7.6.6. Liquid
- 11.3.8.7.6.7. Others
- 11.3.9. Botanicals
- 11.3.9.1. Tablets
- 11.3.9.2. Capsules
- 11.3.9.3. Soft Gels
- 11.3.9.4. Powders
- 11.3.9.5. Gummies
- 11.3.9.6. Liquid
- 11.3.9.7. Others
- 11.3.10. Protein & amino acids
- 11.3.10.1. Tablets
- 11.3.10.2. Capsules
- 11.3.10.3. Soft Gels
- 11.3.10.4. Powders
- 11.3.10.5. Gummies
- 11.3.10.6. Liquid
- 11.3.10.7. Others
- 11.3.10.7.1. Collagen
- 11.3.10.7.1.1. Tablets
- 11.3.10.7.1.2. Capsules
- 11.3.10.7.1.3. Soft Gels
- 11.3.10.7.1.4. Powders
- 11.3.10.7.1.5. Gummies
- 11.3.10.7.1.6. Liquid
- 11.3.10.7.1.7. Others
- 11.3.10.7.2. Others
- 11.3.10.7.2.1. Tablets
- 11.3.10.7.2.2. Capsules
- 11.3.10.7.2.3. Soft Gels
- 11.3.10.7.2.4. Powders
- 11.3.10.7.2.5. Gummies
- 11.3.10.7.2.6. Liquid
- 11.3.10.7.2.7. Others
- 11.3.11. Fibers & Specialty Carbohydrates
- 11.3.11.1. Tablets
- 11.3.11.2. Capsules
- 11.3.11.3. Soft Gels
- 11.3.11.4. Powders
- 11.3.11.5. Gummies
- 11.3.11.6. Liquid
- 11.3.11.7. Others
- 11.3.12. Omega Fatty Acids
- 11.3.12.1. Tablets
- 11.3.12.2. Capsules
- 11.3.12.3. Soft Gels
- 11.3.12.4. Powders
- 11.3.12.5. Gummies
- 11.3.12.6. Liquid
- 11.3.12.7. Others
- 11.3.13. Probiotics
- 11.3.13.1. Tablets
- 11.3.13.2. Capsules
- 11.3.13.3. Soft Gels
- 11.3.13.4. Powders
- 11.3.13.5. Gummies
- 11.3.13.6. Liquid
- 11.3.13.7. Others
- 11.3.14. Prebiotics & Postbiotics
- 11.3.14.1. Tablets
- 11.3.14.2. Capsules
- 11.3.14.3. Soft Gels
- 11.3.14.4. Powders
- 11.3.14.5. Gummies
- 11.3.14.6. Liquid
- 11.3.14.7. Others
- 11.3.15. Others
- 11.3.15.1. Tablets
- 11.3.15.2. Capsules
- 11.3.15.3. Soft Gels
- 11.3.15.4. Powders
- 11.3.15.5. Gummies
- 11.3.15.6. Liquid
- 11.3.15.7. Others
- Chapter 12. U.S. dietary supplements market: Form-End User Estimates & Trend Analysis
- 12.1. U.S. dietary supplements market, By Form-End User: Key Takeaways
- 12.2. Form-End User Movement Analysis & Market Share, 2024 & 2033
- 12.3. Market Estimates & Forecasts, by Form-End User, 2021 - 2033 (USD Million)
- 12.3.1. Tablets
- 12.3.1.1. Adults
- 12.3.1.1.1. Millennials
- 12.3.1.1.1.1. Male
- 12.3.1.1.1.2. Female
- 12.3.1.1.1.3. Pregnant Women
- 12.3.1.1.1.4. Non-pregnant Women
- 12.3.1.1.2. Gen X
- 12.3.1.1.2.1. Male
- 12.3.1.1.2.2. Female
- 12.3.1.1.2.3. Pregnant Women
- 12.3.1.1.2.4. Non-pregnant Women
- 12.3.1.1.3. Gen Z
- 12.3.1.1.3.1. Male
- 12.3.1.1.3.2. Female
- 12.3.1.1.3.3. Pregnant Women
- 12.3.1.1.3.4. Non-pregnant Women
- 12.3.1.1.4. Boomers
- 12.3.1.1.4.1. Male
- 12.3.1.1.4.2. Female
- 12.3.1.2. Geriatric
- 12.3.1.3. Children
- 12.3.1.4. Infants
- 12.3.2. Capsules
- 12.3.2.1.1. Millennials
- 12.3.2.1.1.1. Male
- 12.3.2.1.1.2. Female
- 12.3.2.1.1.3. Pregnant Women
- 12.3.2.1.1.4. Non-pregnant Women
- 12.3.2.1.2. Gen X
- 12.3.2.1.2.1. Male
- 12.3.2.1.2.2. Female
- 12.3.2.1.2.3. Pregnant Women
- 12.3.2.1.2.4. Non-pregnant Women
- 12.3.2.1.3. Gen Z
- 12.3.2.1.3.1. Male
- 12.3.2.1.3.2. Female
- 12.3.2.1.3.3. Pregnant Women
- 12.3.2.1.3.4. Non-pregnant Women
- 12.3.2.1.4. Boomers
- 12.3.2.1.4.1. Male
- 12.3.2.1.4.2. Female
- 12.3.2.2. Geriatric
- 12.3.2.3. Children
- 12.3.2.4. Infants
- 12.3.3. Soft Gels
- 12.3.3.1.1. Millennials
- 12.3.3.1.1.1. Male
- 12.3.3.1.1.2. Female
- 12.3.3.1.1.3. Pregnant Women
- 12.3.3.1.1.4. Non-pregnant Women
- 12.3.3.1.2. Gen X
- 12.3.3.1.2.1. Male
- 12.3.3.1.2.2. Female
- 12.3.3.1.2.3. Pregnant Women
- 12.3.3.1.2.4. Non-pregnant Women
- 12.3.3.1.3. Gen Z
- 12.3.3.1.3.1. Male
- 12.3.3.1.3.2. Female
- 12.3.3.1.3.3. Pregnant Women
- 12.3.3.1.3.4. Non-pregnant Women
- 12.3.3.1.4. Boomers
- 12.3.3.1.4.1. Male
- 12.3.3.1.4.2. Female
- 12.3.3.2. Geriatric
- 12.3.3.3. Children
- 12.3.3.4. Infants
- 12.3.4. Powders
- 12.3.4.1.1. Millennials
- 12.3.4.1.1.1. Male
- 12.3.4.1.1.2. Female
- 12.3.4.1.1.3. Pregnant Women
- 12.3.4.1.1.4. Non-pregnant Women
- 12.3.4.1.2. Gen X
- 12.3.4.1.2.1. Male
- 12.3.4.1.2.2. Female
- 12.3.4.1.2.3. Pregnant Women
- 12.3.4.1.2.4. Non-pregnant Women
- 12.3.4.1.3. Gen Z
- 12.3.4.1.3.1. Male
- 12.3.4.1.3.2. Female
- 12.3.4.1.3.3. Pregnant Women
- 12.3.4.1.3.4. Non-pregnant Women
- 12.3.4.1.4. Boomers
- 12.3.4.1.4.1. Male
- 12.3.4.1.4.2. Female
- 12.3.4.2. Geriatric
- 12.3.4.3. Children
- 12.3.4.4. Infants
- 12.3.5. Gummies
- 12.3.5.1.1. Millennials
- 12.3.5.1.1.1. Male
- 12.3.5.1.1.2. Female
- 12.3.5.1.1.3. Pregnant Women
- 12.3.5.1.1.4. Non-pregnant Women
- 12.3.5.1.2. Gen X
- 12.3.5.1.2.1. Male
- 12.3.5.1.2.2. Female
- 12.3.5.1.2.3. Pregnant Women
- 12.3.5.1.2.4. Non-pregnant Women
- 12.3.5.1.3. Gen Z
- 12.3.5.1.3.1. Male
- 12.3.5.1.3.2. Female
- 12.3.5.1.3.3. Pregnant Women
- 12.3.5.1.3.4. Non-pregnant Women
- 12.3.5.1.4. Boomers
- 12.3.5.1.4.1. Male
- 12.3.5.1.4.2. Female
- 12.3.5.2. Geriatric
- 12.3.5.3. Children
- 12.3.5.4. Infants
- 12.3.6. Liquid
- 12.3.6.1.1. Millennials
- 12.3.6.1.1.1. Male
- 12.3.6.1.1.2. Female
- 12.3.6.1.1.3. Pregnant Women
- 12.3.6.1.1.4. Non-pregnant Women
- 12.3.6.1.2. Gen X
- 12.3.6.1.2.1. Male
- 12.3.6.1.2.2. Female
- 12.3.6.1.2.3. Pregnant Women
- 12.3.6.1.2.4. Non-pregnant Women
- 12.3.6.1.3. Gen Z
- 12.3.6.1.3.1. Male
- 12.3.6.1.3.2. Female
- 12.3.6.1.3.3. Pregnant Women
- 12.3.6.1.3.4. Non-pregnant Women
- 12.3.6.1.4. Boomers
- 12.3.6.1.4.1. Male
- 12.3.6.1.4.2. Female
- 12.3.6.2. Geriatric
- 12.3.6.3. Children
- 12.3.6.4. Infants
- 12.3.7. Others
- 12.3.7.1.1. Millennials
- 12.3.7.1.1.1. Male
- 12.3.7.1.1.2. Female
- 12.3.7.1.1.3. Pregnant Women
- 12.3.7.1.1.4. Non-pregnant Women
- 12.3.7.1.2. Gen X
- 12.3.7.1.2.1. Male
- 12.3.7.1.2.2. Female
- 12.3.7.1.2.3. Pregnant Women
- 12.3.7.1.2.4. Non-pregnant Women
- 12.3.7.1.3. Gen Z
- 12.3.7.1.3.1. Male
- 12.3.7.1.3.2. Female
- 12.3.7.1.3.3. Pregnant Women
- 12.3.7.1.3.4. Non-pregnant Women
- 12.3.7.1.4. Boomers
- 12.3.7.1.4.1. Male
- 12.3.7.1.4.2. Female
- 12.3.7.2. Geriatric
- 12.3.7.3. Children
- 12.3.7.4. Infants
- Chapter 13. U.S. dietary supplements market: Form-Application Estimates & Trend Analysis
- 13.1. U.S. dietary supplements market, By Form-Application: Key Takeaways
- 13.2. Form-Application Movement Analysis & Market Share, 2024 & 2033
- 13.3. Market Estimates & Forecasts, by Form-Application, 2021 - 2033 (USD Million)
- 13.3.1. Tablets
- 13.3.1.1. Bone & Joint Health
- 13.3.1.2. Gastrointestinal Health
- 13.3.1.3. Immunity
- 13.3.1.4. Cardiac Health
- 13.3.1.5. Diabetes
- 13.3.1.6. Anti-cancer
- 13.3.1.7. Lungs Detox/Cleanse
- 13.3.1.8. Skin/ Hair/ Nails
- 13.3.1.9. Sexual Health
- 13.3.1.10. Brain/Mental Health
- 13.3.1.11. Insomnia
- 13.3.1.12. Menopause
- 13.3.1.13. Anti-aging
- 13.3.1.14. Prenatal Health
- 13.3.1.15. Others
- 13.3.2. Capsules
- 13.3.2.1. Bone & Joint Health
- 13.3.2.2. Gastrointestinal Health
- 13.3.2.3. Immunity
- 13.3.2.4. Cardiac Health
- 13.3.2.5. Diabetes
- 13.3.2.6. Anti-cancer
- 13.3.2.7. Lungs Detox/Cleanse
- 13.3.2.8. Skin/ Hair/ Nails
- 13.3.2.9. Sexual Health
- 13.3.2.10. Brain/Mental Health
- 13.3.2.11. Insomnia
- 13.3.2.12. Menopause
- 13.3.2.13. Anti-aging
- 13.3.2.14. Prenatal Health
- 13.3.2.15. Others
- 13.3.3. Soft Gel
- 13.3.3.1. Bone & Joint Health
- 13.3.3.2. Gastrointestinal Health
- 13.3.3.3. Immunity
- 13.3.3.4. Cardiac Health
- 13.3.3.5. Diabetes
- 13.3.3.6. Anti-cancer
- 13.3.3.7. Lungs Detox/Cleanse
- 13.3.3.8. Skin/ Hair/ Nails
- 13.3.3.9. Sexual Health
- 13.3.3.10. Brain/Mental Health
- 13.3.3.11. Insomnia
- 13.3.3.12. Menopause
- 13.3.3.13. Anti-aging
- 13.3.3.14. Prenatal Health
- 13.3.3.15. Others
- 13.3.4. Powder
- 13.3.4.1. Bone & Joint Health
- 13.3.4.2. Gastrointestinal Health
- 13.3.4.3. Immunity
- 13.3.4.4. Cardiac Health
- 13.3.4.5. Diabetes
- 13.3.4.6. Anti-cancer
- 13.3.4.7. Lungs Detox/Cleanse
- 13.3.4.8. Skin/ Hair/ Nails
- 13.3.4.9. Sexual Health
- 13.3.4.10. Brain/Mental Health
- 13.3.4.11. Insomnia
- 13.3.4.12. Menopause
- 13.3.4.13. Anti-aging
- 13.3.4.14. Prenatal Health
- 13.3.4.15. Others
- 13.3.5. Gummies
- 13.3.5.1. Bone & Joint Health
- 13.3.5.2. Gastrointestinal Health
- 13.3.5.3. Immunity
- 13.3.5.4. Cardiac Health
- 13.3.5.5. Diabetes
- 13.3.5.6. Anti-cancer
- 13.3.5.7. Lungs Detox/Cleanse
- 13.3.5.8. Skin/ Hair/ Nails
- 13.3.5.9. Sexual Health
- 13.3.5.10. Brain/Mental Health
- 13.3.5.11. Insomnia
- 13.3.5.12. Menopause
- 13.3.5.13. Anti-aging
- 13.3.5.14. Prenatal Health
- 13.3.5.15. Others
- 13.3.6. Liquid
- 13.3.6.1. Bone & Joint Health
- 13.3.6.2. Gastrointestinal Health
- 13.3.6.3. Immunity
- 13.3.6.4. Cardiac Health
- 13.3.6.5. Diabetes
- 13.3.6.6. Anti-cancer
- 13.3.6.7. Lungs Detox/Cleanse
- 13.3.6.8. Skin/ Hair/ Nails
- 13.3.6.9. Sexual Health
- 13.3.6.10. Brain/Mental Health
- 13.3.6.11. Insomnia
- 13.3.6.12. Menopause
- 13.3.6.13. Anti-aging
- 13.3.6.14. Prenatal Health
- 13.3.6.15. Others
- 13.3.7. Others
- 13.3.7.1. Bone & Joint Health
- 13.3.7.2. Gastrointestinal Health
- 13.3.7.3. Immunity
- 13.3.7.4. Cardiac Health
- 13.3.7.5. Diabetes
- 13.3.7.6. Anti-cancer
- 13.3.7.7. Lungs Detox/Cleanse
- 13.3.7.8. Skin/ Hair/ Nails
- 13.3.7.9. Sexual Health
- 13.3.7.10. Brain/Mental Health
- 13.3.7.11. Insomnia
- 13.3.7.12. Menopause
- 13.3.7.13. Anti-aging
- 13.3.7.14. Prenatal Health
- 13.3.7.15. Others
- Chapter 14. U.S. Dietary Supplements Market: Competitive Analysis
- 14.1. Recent developments & impact analysis, by key market participants
- 14.2. Company Categorization
- 14.3. Participant’s Overview
- 14.4. Financial Performance
- 14.5. Product Benchmarking
- 14.6. Company Market Share Analysis, 2024 (%)
- 14.7. Company Heat Map Analysis
- 14.8. Strategy Mapping
- 14.9. Company Profiles
- 14.9.1. Bayer AG
- 14.9.1.1. Company Overview
- 14.9.1.2. Financial Performance
- 14.9.1.3. Product Portfolios
- 14.9.1.4. Strategic Initiatives
- 14.9.2. Glanbia plc
- 14.9.2.1. Company Overview
- 14.9.2.2. Financial Performance
- 14.9.2.3. Product Portfolios
- 14.9.2.4. Strategic Initiatives
- 14.9.3. Pfizer Inc.
- 14.9.3.1. Company Overview
- 14.9.3.2. Financial Performance
- 14.9.3.3. Product Portfolios
- 14.9.3.4. Strategic Initiatives
- 14.9.4. Archer Daniels Midland Company
- 14.9.4.1. Company Overview
- 14.9.4.2. Financial Performance
- 14.9.4.3. Product Portfolios
- 14.9.4.4. Strategic Initiatives
- 14.9.5. GlaxoSmithKline plc
- 14.9.5.1. Company Overview
- 14.9.5.2. Financial Performance
- 14.9.5.3. Product Portfolios
- 14.9.5.4. Strategic Initiatives
- 14.9.6. NU SKIN
- 14.9.6.1. Company Overview
- 14.9.6.2. Financial Performance
- 14.9.6.3. Product Portfolios
- 14.9.6.4. Strategic Initiatives
- 14.9.7. Herbalife Nutrition
- 14.9.7.1. Company Overview
- 14.9.7.2. Financial Performance
- 14.9.7.3. Product Portfolios
- 14.9.7.4. Strategic Initiatives
- 14.9.8. Nature’s Sunshine Products Inc.
- 14.9.8.1. Company Overview
- 14.9.8.2. Financial Performance
- 14.9.8.3. Product Portfolios
- 14.9.8.4. Strategic Initiatives
- 14.9.9. DuPont de Nemours Inc.
- 14.9.9.1. Company Overview
- 14.9.9.2. Financial Performance
- 14.9.9.3. Product Portfolios
- 14.9.9.4. Strategic Initiatives
- 14.9.10. NOW Foods
- 14.9.10.1. Company Overview
- 14.9.10.2. Financial Performance
- 14.9.10.3. Product Portfolios
- 14.9.10.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
